tradingkey.logo

Burning Rock Biotech Ltd

BNR
查看詳細走勢圖
23.390USD
+1.690+7.79%
收盤 12/22, 16:00美東報價延遲15分鐘
211.19M總市值
虧損本益比TTM

Burning Rock Biotech Ltd

23.390
+1.690+7.79%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+7.79%

5天

+48.51%

1月

+64.14%

6月

+540.82%

今年開始到現在

+246.52%

1年

+255.47%

查看詳細走勢圖

TradingKey Burning Rock Biotech Ltd股票評分

單位: USD 更新時間: 2025-12-19

操作建議

Burning Rock Biotech Ltd當前公司基本面數據相對非常健康,增長潛力很大。當前估值合理,在醫療服務供應商行業排名60/78位。機構持股佔比非常高,中期看,股價處於上升通道。近一個月,市場表現很強,技術面和基本面綜合得分較高,很強的走勢得到基本面和技術面的印證。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Burning Rock Biotech Ltd評分

相關信息

行業排名
60 / 78
全市場排名
356 / 4582
所屬行業
醫療服務供應商

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 0 分析師
--
評級
0.000
目標均價
0.00%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Burning Rock Biotech Ltd亮點

亮點風險
Burning Rock Biotech Ltd is a Company principally engaged in developing and providing cancer therapy selection tests. The Company operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.
業績增長期
公司處於發展階段,最新年度總收入71.08M美元
估值低估
公司最新PE估值-13.35,處於3年歷史低位
詹姆斯·西蒙斯持倉
明星投資者詹姆斯·西蒙斯持倉,最新持倉31.72K股

Burning Rock Biotech Ltd新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Burning Rock Biotech Ltd簡介

Burning Rock Biotech Ltd is a Company principally engaged in developing and providing cancer therapy selection tests. The Company operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.
公司代碼BNR
公司Burning Rock Biotech Ltd
CEOHan (Yusheng)
網址https://www.brbiotech.com/

常見問題

Burning Rock Biotech Ltd(BNR)的當前股價是多少?

Burning Rock Biotech Ltd(BNR)的當前股價是 23.390。

Burning Rock Biotech Ltd 的股票代碼是什麼?

Burning Rock Biotech Ltd的股票代碼是BNR。

Burning Rock Biotech Ltd股票的52週最高點是多少?

Burning Rock Biotech Ltd股票的52週最高點是23.590。

Burning Rock Biotech Ltd股票的52週最低點是多少?

Burning Rock Biotech Ltd股票的52週最低點是2.180。

Burning Rock Biotech Ltd的市值是多少?

Burning Rock Biotech Ltd的市值是211.19M。

Burning Rock Biotech Ltd的淨利潤是多少?

Burning Rock Biotech Ltd的淨利潤為-346.63M。

現在Burning Rock Biotech Ltd(BNR)的股票是買入、持有還是賣出?

根據分析師評級,Burning Rock Biotech Ltd(BNR)的總體評級為--,目標價格為--。

Burning Rock Biotech Ltd(BNR)股票的每股收益(EPS TTM)是多少

Burning Rock Biotech Ltd(BNR)股票的每股收益(EPS TTM)是-1.626。
KeyAI